Macular buckling versus vitrectomy on macular hole associated macular detachment in eyes with high myopia: a randomised trial. Issue 4 (4th January 2021)

• Record Type: Journal Article
• Authors: Zhao, Xiujuan; Li, Yonghao; Ma, Wei; Lian, Ping; Yu, Xiling; Chen, Shida; Huang, Xia; Liu, Bingqian; Lu, Lin
• Is Part Of: British journal of ophthalmology. Volume 106:Issue 4(2022)
• Page Start: 582
• Page End: 586
• Publication Date: 2021-01-04
• Subjects: treatment surgery -- retina; Ophthalmology -- Periodicals; 617.7
• DOI: 10.1136/bjophthalmol-2020-317800
• Languages: English
• ISSNs: 0007-1161

Abstract

Abstract : Aim: To compare the efficacy of macular buckling (MB) and pars plana vitrectomy (PPV) for full-thickness macular holes (FTMH) and associated macular detachment (MD) in highly myopic eyes. Methods: Prospective interventional case series of eyes undergoing PPV or MB for FTMH and MD. Main outcome measures: Best-corrected visual acuity (BCVA) at postoperative month 24. Other measured outcomes include the initial surgical success rate, macular hole closure rate and the progression of myopic maculopathy. Results: A total of 53 eyes from 53 participants were included in this study (26 participants receiving MB and 27 participants receiving PPV), and finally 49 eyes from 49 participants (25 participants in the MB group and 24 participants in the PPV group) were analysed. At postoperative month 24, the BCVA had improved significantly in those that underwent either MB (p<0.001) or PPV (p=0.04). The difference between the groups was not significant (p=0.653). The surgical failure rate after the primary treatment was significantly higher in the PPV group than the MB group (25.00% vs 4.00%, respectively; p=0.04). The macular closure rate was higher in the MB group compared with the PPV group, but the difference was not statistically significant (64.00% vs 58.33%, respectively; p=0.45). Myopic maculopathy development may be more severe following PPV than following MB surgery. Conclusion: Patients with high myopia obtained anatomical and functional improvements from either MB or PPV. However, MB achieved a significantly higher success rate in retinal reattachment compared with PPV. Trial registration number: NCT03433547 .